[{"name":"Home","site_name":"Press | Company | Siemens","description":"","url_str":"\/global\/","level":0,"image":"","base_root":"https:\/\/press.siemens.com","base_nid":"5","base_nodepath":"\/node\/5","base_path":"\/global\/","base_secure_url":"https:\/\/press.siemens.com\/global","children":null}]
It looks like you are using a browser that is not fully supported. Please note that there might be constraints on site display and
usability.
For the best experience we suggest that you download the newest version of a supported browser:
Save the date2021-05-07 07:30:00Europe/Parisuse-titleSecond Quarter Results FY 2021
Orders climbed 11% on a comparable basis, excluding currency translation and portfolio effects, and revenue rose 9%
On a nominal basis, orders increased 8% to €15.9 billion, driven by double-digit growth in Siemens Healthineers, and revenue rose 6%, to €14.7 billion, on growth in all industrial businesses; the book-to-bill ratio was 1.08
Adjusted EBITA Industrial Businesses was €2.1 billion, a 31% increase on strong performances in all Industrial Businesses, resulting in Adjusted EBITA margin Industrial Businesses of 15.1%
Net income and basic earnings per share (EPS) were sharply higher, at €2.4 billion and €2.82, respectively, on higher Adjusted EBITA Industrial Businesses, a €0.9 billion gain on the sale of Flender GmbH (Flender) within discontinued operations, and favorable effects outside Industrial Businesses; in Q2 FY 2020 net income of €0.7 billion and basic EPS of €0.80 included a loss of €0.3 billion from discontinued operations
Excellent Free cash flow from continuing and discontinued operations of €1.2 billion (Q2 FY 2020: €0.1 billion), including increases in all industrial businesses
Munich
We released our second quarter results for fiscal 2021 on May 7, 2021. The conference call for journalists and the analyst was broadcasted live.
Save the date2021-05-07 07:30:00Europe/Parisuse-titleSecond Quarter Results FY 2021
Orders climbed 11% on a comparable basis, excluding currency translation and portfolio effects, and revenue rose 9%
On a nominal basis, orders increased 8% to €15.9 billion, driven by double-digit growth in Siemens Healthineers, and revenue rose 6%, to €14.7 billion, on growth in all industrial businesses; the book-to-bill ratio was 1.08
Adjusted EBITA Industrial Businesses was €2.1 billion, a 31% increase on strong performances in all Industrial Businesses, resulting in Adjusted EBITA margin Industrial Businesses of 15.1%
Net income and basic earnings per share (EPS) were sharply higher, at €2.4 billion and €2.82, respectively, on higher Adjusted EBITA Industrial Businesses, a €0.9 billion gain on the sale of Flender GmbH (Flender) within discontinued operations, and favorable effects outside Industrial Businesses; in Q2 FY 2020 net income of €0.7 billion and basic EPS of €0.80 included a loss of €0.3 billion from discontinued operations
Excellent Free cash flow from continuing and discontinued operations of €1.2 billion (Q2 FY 2020: €0.1 billion), including increases in all industrial businesses
Munich
We released our second quarter results for fiscal 2021 on May 7, 2021. The conference call for journalists and the analyst was broadcasted live.